106 related articles for article (PubMed ID: 26560643)
1. Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition.
Ingebrigtsen TS; Marott JL; Lange P; Hallas J; Nordestgaard BG; Vestbo J
Respir Med; 2015 Dec; 109(12):1562-8. PubMed ID: 26560643
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of undertreatment in COPD in the general population.
Ingebrigtsen TS; Marott JL; Vestbo J; Hallas J; Nordestgaard BG; Dahl M; Lange P
Chest; 2013 Dec; 144(6):1811-1818. PubMed ID: 23989916
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM
Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402
[TBL] [Abstract][Full Text] [Related]
5. Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease.
Ingebrigtsen TS; Marott JL; Vestbo J; Nordestgaard BG; Hallas J; Lange P
Respirology; 2015 Jan; 20(1):101-7. PubMed ID: 25297724
[TBL] [Abstract][Full Text] [Related]
6. Predicting exacerbations in COPD in the Danish general population.
Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Nordestgaard BG; Lange P
Respir Med; 2024 Apr; 224():107557. PubMed ID: 38355020
[TBL] [Abstract][Full Text] [Related]
7. Patterns and characterization of COPD exacerbations using real-time data collection.
Ejiofor SI; Stolk J; Fernandez P; Stockley RA
Int J Chron Obstruct Pulmon Dis; 2017; 12():427-434. PubMed ID: 28182151
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
[TBL] [Abstract][Full Text] [Related]
9. Determinants for changing the treatment of COPD: a regression analysis from a clinical audit.
López-Campos JL; Abad Arranz M; Calero Acuña C; Romero Valero F; Ayerbe García R; Hidalgo Molina A; Aguilar Perez-Grovas RI; García Gil F; Casas Maldonado F; Caballero Ballesteros L; Sánchez Palop M; Pérez-Tejero D; Segado A; Calvo Bonachera J; Hernández Sierra B; Doménech A; Arroyo Varela M; González Vargas F; Cruz Rueda JJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():1171-8. PubMed ID: 27330285
[TBL] [Abstract][Full Text] [Related]
10. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
[TBL] [Abstract][Full Text] [Related]
11. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study.
Roede BM; Bresser P; Bindels PJ; Kok A; Prins M; ter Riet G; Geskus RB; Herings RM; Prins JM
Thorax; 2008 Nov; 63(11):968-73. PubMed ID: 18682520
[TBL] [Abstract][Full Text] [Related]
13. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
[TBL] [Abstract][Full Text] [Related]
14. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
[TBL] [Abstract][Full Text] [Related]
15. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
[TBL] [Abstract][Full Text] [Related]
16. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
17. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
Thomsen M; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
[TBL] [Abstract][Full Text] [Related]
19. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA
Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
[TBL] [Abstract][Full Text] [Related]
20. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease.
Calverley PM
Proc Am Thorac Soc; 2004; 1(3):161-6. PubMed ID: 16113429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
